New hope for kids with eye inflammation: baricitinib trial shows promise
NCT ID NCT04088409
First seen Apr 28, 2026 · Last updated Jun 18, 2026 · Updated 8 times
Summary
This study tests whether baricitinib, an oral drug, is safe and effective for children aged 2 to 18 with active uveitis (eye inflammation) linked to juvenile arthritis or a related condition. Participants had not responded well to standard treatments. The main goal is to reduce eye inflammation, with results expected to show if baricitinib can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alder Hey Children's Hospital
Liverpool, England, L14 5AB, United Kingdom
-
Asklepios Klinik Sankt Augustin
Sankt Augustin, North Rhine-Westphalia, 53757, Germany
-
Azienda Ospedaliero Universitaria Meyer
Florence, 50100, Italy
-
Bristol Royal Hospital for Children
Bristol, Bristol, City of, BS2 8BJ, United Kingdom
-
Cambridge Clinical Research Facility
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
-
Centre Hospitalier Universitaire de Poitiers
Poitiers, 86021, France
-
Charité Campus Virchow-Klinikum
Berlin, 13353, Germany
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, 20122, Italy
-
Great Ormond Street Hospital For Children NHS Foundation Trust
London, WC1N 3JH, United Kingdom
-
HELIOS Klinikum Berlin-Buch
Berlin, 13125, Germany
-
Hospital Infantil Universitario Niño Jesús
Madrid, Madrid, Comunidad de, 28009, Spain
-
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona, 08950, Spain
-
Hospital Universitario La Fe de Valencia
Valencia, 46026, Spain
-
Hospital Universitario La Paz
Madrid, Madrid, Comunidad de, 28046, Spain
-
Hôpital Universitaire Necker Enfants Malades
Paris, 75015, France
-
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
-
Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari
Hamburg, 22081, Germany
-
Royal Victoria Infirmary
Newcastle upon Tyne, England, NE1 4LP, United Kingdom
-
Sheffield Children's Hospital
Sheffield, S10 2TH, United Kingdom
-
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, SO16 0YD, United Kingdom
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.